Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04163614 · ClinicalTrials.gov registry record · NA
Blood Pressure Slopes and Ultrafiltration in Hemodialysis Patients
A NA study of Hypertension and End Stage Renal Disease, sponsored by VA Office of Research and Development.
- Recruiting
- Registry status
- NA
- Development phase
- 69
- Enrollment target
- 1
- Study location
NCT04163614: Recruiting NA study of Hypertension and End Stage Renal Disease, sponsored by VA Office of Research and Development.
NCT04163614 is a NA study of Hypertension and End Stage Renal Disease that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 69 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04163614, a NA study of Hypertension and End Stage Renal Disease, is actively recruiting participants, sponsored by VA Office of Research and Development.
- RECRUITING
- Registry status
- NA
- Development phase
- 69 participants
- Enrollment target
- 1
- Study location
Study Summary
Kidney failure has been recognized as one of the most costly chronic conditions among United States Veterans. Approximately 13,000 Veterans develop kidney failure each year, and most require hemodialysis initiation. Hemodialysis patients suffer significantly increased risk of death and hospitalizations, and excessive body fluid is a major cause of this. While empiric aggressive fluid removal during dialysis is one approach to limit fluid overload, this can cause dangerous decreases in blood pressure during dialysis that independently contribute to the high death rate. In this study, I aim to test a new strategy that prescribes fluid removal based on a patient's recent blood pressure patterns during dialysis. This clinical trial will compare my strategy to standard care and assess the outcomes of overall blood pressure change between dialysis treatments in addition to the number of times the blood pressure becomes dangerously low during dialysis. Another aim is to determine how differences in the structure and function of the heart influence blood pressure during dialysis.
Primary Outcome
Will compare between-group difference in change in ambulatory systolic blood pressure from baseline to 4-month follow up
Conditions Studied
Interventions
- OTHER IBPS-Guided Ultrafiltration
Study Locations (1)
Texas
- VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 69 participants |
| Start Date | 2021-02-10 |
| Est. Completion | 2026-07-01 |
| Phase | NA |
What NCT04163614 shows while recruiting
NCT04163614 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 69 participants, a relatively small participant target, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (98% lower).
The record links to 4 conditions, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which IBPS-Guided Ultrafiltration is the first listed.
NCT04163614 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT04163614 about?
NCT04163614 is a clinical study titled "Blood Pressure Slopes and Ultrafiltration in Hemodialysis Patients". Kidney failure has been recognized as one of the most costly chronic conditions among United States Veterans. Approximately 13,000 Veterans develop kidney failure each year, and most require hemodialysis initiation. Hemodialysis patients suffer significantly increased risk of death and hospitalizati...
What is the current status of trial NCT04163614?
This trial is currently recruiting. It is a NA study. The enrollment target is 69 participants. The study started on 2021-02-10. Estimated completion is 2026-07-01.
What conditions does trial NCT04163614 study?
This clinical trial studies the following conditions: Hypertension, End Stage Renal Disease, Intradialytic Hypotension, Extracellular Volume Overload.
What interventions are being tested in trial NCT04163614?
The interventions under investigation include: IBPS-Guided Ultrafiltration (OTHER).
Who is sponsoring clinical trial NCT04163614?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04163614 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04163614's enrollment target sits among peer trials
69 339th of 470 higher than 132 of 470 other Hypertension trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
How a Mediterranean Diet With Potatoes Impacts Heart and Metabolic Health in Adults With Pre-Diabetes
RECRUITING · NA
-
Conical Forearm and Cylindrical Upper Arm Non-Invasive Blood Pressure (NIBP) Measurements in Pregnant Patients
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Early Time-Restricted Eating in Older Adults With Hypertension
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04020575 · 69 participants · Phase 1
Autologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*)
- NCT04164641 · 69 participants · NA
Noraxon myoRESEARCH™ Software Gait Analysis Evaluation and Orthotic Gait Correction in Reducing Diabetic Foot Ulceration Or Subsequent Amputation in Patients With a History of a Diabetic Foot Ulceration
- NCT04493372 · 69 participants · NA
Deciphering Preserved Autonomic Function After Spinal Cord Injury
- NCT04762199 · 69 participants · Phase 1
MRX-2843 and Osimertinib for the Treatment of Advanced EGFR Mutant Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI